208 related articles for article (PubMed ID: 23095505)
1. CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications.
Zhao S; Zhang H; Xing Y; Natkunam Y
Am J Surg Pathol; 2013 Feb; 37(2):250-8. PubMed ID: 23095505
[TBL] [Abstract][Full Text] [Related]
2. Use of CD137 ligand expression in the detection of small B-cell lymphomas involving the bone marrow.
Zhao S; Xing Y; Natkunam Y
Hum Pathol; 2014 May; 45(5):1024-30. PubMed ID: 24746207
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression.
Ho WT; Pang WL; Chong SM; Castella A; Al-Salam S; Tan TE; Moh MC; Koh LK; Gan SU; Cheng CK; Schwarz H
Cancer Res; 2013 Jan; 73(2):652-61. PubMed ID: 23204227
[TBL] [Abstract][Full Text] [Related]
4. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
5. Expression of the serpin centerin defines a germinal center phenotype in B-cell lymphomas.
Paterson MA; Hosking PS; Coughlin PB
Am J Clin Pathol; 2008 Jul; 130(1):117-26. PubMed ID: 18550480
[TBL] [Abstract][Full Text] [Related]
6. CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
Anderson MW; Zhao S; Freud AG; Czerwinski DK; Kohrt H; Alizadeh AA; Houot R; Azambuja D; Biasoli I; Morais JC; Spector N; Molina-Kirsch HF; Warnke RA; Levy R; Natkunam Y
Am J Pathol; 2012 Sep; 181(3):795-803. PubMed ID: 22901750
[TBL] [Abstract][Full Text] [Related]
7. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
Kingma DW; Imus P; Xie XY; Jasper G; Sorbara L; Stewart C; Stetler-Stevenson M
Cytometry; 2002 Oct; 50(5):243-8. PubMed ID: 12360573
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of adaptor protein PAG: correlation between secondary lymphatic follicle and histogenetically related malignant lymphomas.
Svec A; Velenská Z; Horejsí V
Immunol Lett; 2005 Aug; 100(1):94-7. PubMed ID: 15975665
[TBL] [Abstract][Full Text] [Related]
9. CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival.
Palma C; Binaschi M; Bigioni M; Maggi CA; Goso C
Int J Cancer; 2004 Jan; 108(3):390-8. PubMed ID: 14648705
[TBL] [Abstract][Full Text] [Related]
10. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
Almasri NM; Iturraspe JA; Braylan RC
Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
[TBL] [Abstract][Full Text] [Related]
11. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
12. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
13. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas.
Wada K; Maeda K; Tajima K; Kato T; Kobata T; Yamakawa M
Histopathology; 2009 Jan; 54(2):221-32. PubMed ID: 19207947
[TBL] [Abstract][Full Text] [Related]
14. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.
Marmey B; Boix C; Barbaroux JB; Dieu-Nosjean MC; Diebold J; Audouin J; Fridman WH; Mueller CG; Molina TJ
Hum Pathol; 2006 Jan; 37(1):68-77. PubMed ID: 16360418
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD137 and CD137 ligand in colorectal cancer patients.
Dimberg J; Hugander A; Wågsäter D
Oncol Rep; 2006 May; 15(5):1197-200. PubMed ID: 16596186
[TBL] [Abstract][Full Text] [Related]
16. Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody.
Nakamura N; Hase H; Sakurai D; Yoshida S; Abe M; Tsukada N; Takizawa J; Aoki S; Kojima M; Nakamura S; Kobata T
Virchows Arch; 2005 Jul; 447(1):53-60. PubMed ID: 16025281
[TBL] [Abstract][Full Text] [Related]
17. The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphoma.
Masir N; Jones M; Lee AM; Goff LK; Clear AJ; Lister A; Marafioti T; Mason DY
Histopathology; 2010 Apr; 56(5):617-26. PubMed ID: 20459572
[TBL] [Abstract][Full Text] [Related]
18. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
[TBL] [Abstract][Full Text] [Related]
19. Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma.
Middendorp S; Xiao Y; Song JY; Peperzak V; Krijger PH; Jacobs H; Borst J
Blood; 2009 Sep; 114(11):2280-9. PubMed ID: 19608748
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]